A Study to Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation
Clinical trial NCT04627142 · TERMINATED
Trial details
- NCT number
- NCT04627142
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-23
- Primary completion
- 2022-01-18
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.